Who invested in Adela

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 7 months ago

Funding summaryUpdated 26 Oct 2026

$53Mraised across 2 rounds since 2023, from 2 sources

$48MSeries A$5.0MRound

Latest round: Round, $5.0MApr 2026
Biggest round: $48MSeries A · Sept 2023
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202420252026

$48MSeries A$5.0MRound

First round: Series A, $48M
Biggest round: $48M
Between rounds: 2.6 years

The rounds

Apr 2026
Round$5.0M3 returning
Source recordedSEC filing: $5.0M sold
Sept 2023
Series A$48M3 new
Source recordedSEC filing: $28M sold, first sale Jul 2023

Founders and team

From Adela's own website: 2 founders, 6 on the team.

David ScheerCo-founder & Board Chair, Adela

Maneesh JainCo-Founder, Adela

Lindsay MateoPresident & Chief Executive Officer
Alan WilliamsChief Operating Officer
Anne-Renee HartmanChief Medical Officer
Daniel De CarvalhoChief Scientific Officer
Scott BratmanChief Innovation Officer
Paul BrownBoard Member for Decheng Capital

AdvisersGary Bader

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2023Round2026

OrbiMed

RA Capital Management

Deerfield

Everyone who backed them

OrbiMedPrivate equity2rounds

RA Capital ManagementPrivate equity2rounds

DeerfieldVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Adela as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.